Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia

The American Journal of Cardiology
Antonios M XydakisC M Ballantyne

Abstract

Combination lipid-reducing therapy is increasingly used, particularly for the management of severe or combined dyslipidemia in patients at high risk for coronary heart disease. To assess the potential additive effects of combining the cholesterol absorption inhibitor ezetimibe with a bile acid resin (BAR), a prospective chart review was performed of 40 patients in whom ezetimibe 10 mg/day was added to a stable regimen that included a BAR. At an average follow-up of 107 +/- 57 days, ezetimibe coadministration significantly reduced total cholesterol by 18%, triglycerides by 14%, and low-density lipoprotein cholesterol by 19% (all p < or =0.03), without significantly changing high-density lipoprotein cholesterol, and the combination was well tolerated.

References

Aug 4, 2001·The Annals of Pharmacotherapy·M A Aldridge, M K Ito
Nov 9, 2002·The American Journal of Cardiology·Claude GagnéUNKNOWN Ezetimibe Study Group
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Nov 8, 2003·Clinical Therapeutics·LilyAnn Jeu, Judy W M Cheng
Nov 26, 2003·European Journal of Clinical Investigation·T A Miettinen, H Gylling
Feb 21, 2004·Science·Scott W AltmannMichael P Graziano
Feb 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Eric J SmartSteven A Farber

❮ Previous
Next ❯

Citations

Jul 25, 2009·Current Treatment Options in Cardiovascular Medicine·William H Smiley IIILaurence S Sperling
Nov 22, 2011·Current Opinion in Lipidology·Harry R DavisThomas Musliner
Jan 1, 2009·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Ronald B Goldberg
Dec 4, 2010·Vascular Health and Risk Management·Ian Hamilton-CraigStan Woodhouse
Jul 6, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Z Reiner
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Irene F Gazi, Dimitri P Mikhailidis
May 24, 2006·Expert Review of Cardiovascular Therapy·Annemarie Armani, Peter P Toth
Mar 29, 2011·Expert Review of Cardiovascular Therapy·Aris P AgouridisMoses S Elisaf
Jun 2, 2007·Expert Opinion on Drug Metabolism & Toxicology·Mary Ellen Sweeney, Rebecca R Johnson
Mar 23, 2011·Expert Opinion on Drug Safety·Michel Farnier
Apr 1, 2006·Current Medical Research and Opinion·Stella S Daskalopoulou, Dimitri P Mikhailidis
Nov 2, 2006·Current Medical Research and Opinion·Harold BaysMichael Jones
Feb 23, 2008·Current Medical Research and Opinion·M FlorentinM S Elisaf
Jul 25, 2013·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Ovidio Muñiz Grijalvo, Jose Villar Ortiz
Oct 1, 2008·Journal of Clinical Lipidology·Hanna Slim, Paul D Thompson
May 23, 2008·Journal of Clinical Lipidology·Stephen D Turley
Mar 21, 2007·The American Journal of Cardiology·Peter P Toth
Oct 12, 2005·Atherosclerosis·Michel R HoenigJulie H Campbell
Jan 15, 2014·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Guenther SilbernagelWinfried März
Apr 17, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kenneth K C LeeBrian Tomlinson
Feb 25, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Alberto CorsiniMichel Farnier
Apr 28, 2006·The Annals of Pharmacotherapy·Charles D MeyersNathan D Wong
Apr 15, 2014·Clinical Pharmacology and Therapeutics·R TompkinsH Weintraub
Aug 18, 2009·Fundamental & Clinical Pharmacology·Zeljko Reiner
Nov 1, 2010·Expert Review of Endocrinology & Metabolism·Adie Viljoen, Anthony S Wierzbicki
May 13, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Nicole E JelesoffJohn R Guyton
Mar 16, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Shannon M RiversRobert A Hamilton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.